Biomark Diagnostics Statistics
Total Valuation
BMKDF has a market cap or net worth of 21.43 million. The enterprise value is 22.53 million.
| Market Cap | 21.43M |
| Enterprise Value | 22.53M |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 105.09M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +709.75% |
| Shares Change (QoQ) | +874.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 53.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 198.94 |
| PB Ratio | -28.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.09 |
| EV / Sales | 186.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -37.71 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.73 |
| Interest Coverage | -27.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -107.55% |
| Return on Invested Capital (ROIC) | -144.93% |
| Return on Capital Employed (ROCE) | 297.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.87% in the last 52 weeks. The beta is -0.34, so BMKDF's price volatility has been lower than the market average.
| Beta (5Y) | -0.34 |
| 52-Week Price Change | +28.87% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 53.47 |
| Average Volume (20 Days) | 6,494 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMKDF had revenue of 107,746 and -1.32 million in losses. Loss per share was -0.00.
| Revenue | 107,746 |
| Gross Profit | 107,746 |
| Operating Income | -1.33M |
| Pretax Income | -1.32M |
| Net Income | -1.32M |
| EBITDA | -1.32M |
| EBIT | -1.33M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 61,566 in cash and 1.04 million in debt, giving a net cash position of -974,386.
| Cash & Cash Equivalents | 61,566 |
| Total Debt | 1.04M |
| Net Cash | -974,386 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -763,042 |
| Book Value Per Share | -0.01 |
| Working Capital | -945,883 |
Cash Flow
In the last 12 months, operating cash flow was -594,677 and capital expenditures -2,602, giving a free cash flow of -597,279.
| Operating Cash Flow | -594,677 |
| Capital Expenditures | -2,602 |
| Free Cash Flow | -597,279 |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,235.35% |
| Pretax Margin | -1,223.42% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BMKDF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -709.75% |
| Shareholder Yield | n/a |
| Earnings Yield | -6.15% |
| FCF Yield | -2.79% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMKDF has an Altman Z-Score of -27.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -27.36 |
| Piotroski F-Score | 1 |